Which anti‑inflammatory eye drops should be administered and what is the appropriate duration of therapy?

Anti-Inflammatory Eye Drops: Selection and Duration

For moderate-to-severe ocular inflammation, use short-term topical corticosteroids (preservative-free dexamethasone 0.1%, prednisolone 0.5%, or loteprednol 0.5%) with early introduction of corticosteroid-sparing agents like cyclosporine to facilitate tapering and avoid prolonged steroid exposure beyond 8 weeks. 1

Treatment Algorithm by Severity

Mild Inflammation

• First-line: Preservative-free lubricants 2-4 times daily
• Second-line: Add topical antihistamines (olopatadine 2 times daily for up to 4 months, or ketotifen 2 times daily) 1
• Duration: Continue until symptoms resolve, typically 2-4 weeks

Moderate-to-Severe Inflammation

Initial Phase (Weeks 1-2):

• Corticosteroids:
  • Loteprednol 0.5% gel or suspension 4 times daily for 2 weeks (preferred due to lower IOP risk and reduced neurotoxic preservative) 2
  • Alternative: Preservative-free dexamethasone 0.1% twice daily 3
  • Alternative: Prednisolone acetate 0.5% 1

Tapering Phase (Weeks 3-4):

• Reduce to twice daily for 2 weeks
• Then once daily for final taper

Critical Caveat: Avoid prolonged corticosteroid therapy beyond 8 weeks due to significant risk of glaucoma and cataracts 1

Corticosteroid-Sparing Agents (Introduce Early)

Start simultaneously with corticosteroids or by week 2-3 to facilitate steroid tapering 1:

• Cyclosporine 0.05%: 2-4 times daily, continue long-term as needed 2, 4

  • Takes 4-6 weeks for full effect
  • May cause burning in 17% of patients initially
  • Can be reduced to once daily after 1 year of twice-daily therapy 4

• Lifitegrast 5%: Twice daily for signs and symptoms 4

  • Blocks LFA-1/ICAM-1 interaction
  • Shows benefit over 3 months

• Tacrolimus 0.03%: Three times daily for lid margin inflammation 2

  • Trial for 2-4 weeks; discontinue if ineffective 1

NSAIDs for Specific Conditions

Ketorolac 0.5%: 4 times daily for traumatic corneal abrasions or acute inflammation 5

• Provides rapid pain relief within 24 hours
• Use for 3-7 days maximum

Indomethacin 0.1%: 6 times daily for 3 days, then 4 times daily for 11 days for inflamed pterygium/pinguecula 6

Key Clinical Pitfalls

1. Never exceed 8 weeks of continuous topical corticosteroids without ophthalmology consultation—this threshold marks significant risk for serious complications 1

2. Avoid preserved formulations in severe hyperalgesia—use preservative-free preparations (e.g., compounded methylprednisolone 1%) 2

3. Monitor IOP closely with any corticosteroid use, especially with dexamethasone and prednisolone which have higher penetration than loteprednol 2

4. Start steroid-sparing agents early (by week 2-3) rather than waiting for steroid complications to develop 1

5. For patients requiring >1-2 drops/day of prednisolone 1% for >3 months: Must add or escalate systemic therapy rather than continuing topical steroids alone 7

Duration Summary

• Acute inflammation: 2-4 weeks total with taper
• Chronic inflammation: Transition to steroid-sparing agents by week 2-3
• Maximum corticosteroid duration: 8 weeks (hard stop) 1
• Cyclosporine/Lifitegrast: Long-term maintenance as needed
• NSAIDs: 3-14 days for acute conditions